Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 129-135 , June 2010

Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation

References 

  1. Watchko JF. Exchange transfusion in the management of neonatal hyperbilirubinemia. In:  Maisels MJ,  Watchko JF editor. Neonatal jaundice. London: Harwood; 2000;p. 169–176
  2. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA kernicterus registry (1992 to 2004). J Perinatol. 2009;29:S25–S45
  3. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730–733
  4. Sgro M, Campbell DM, Fallah S, Shah V. Kernicterus–January 2007 to December 2009. Canadian Paediatric Surveillance Program 2009. Available at: http://www.cps.ca/english/surveillance/CPSP/index.htm
  5. Manning D, Todd P, Maxwell M, Platt M-J. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatol Ed. 2007;92:342–346
  6. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89:1213–1217
  7. Banerjee TK, Hazra A, Biswas A, Ray J, et al. Neurological disorders in children and adolescents. Ind J Pediatr. 2009;76:139–146
  8. Mezaal MA, Nouri KA, Abdool S, Safar KA, Nadeem ASM. Cerebral palsy in adults. Consequences of non progressive pathology. Open Neuro J. 2009;3:24–26
  9. Slusher TM, Vreman HJ, McLaren D, et al. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin related morbidity and death in Nigerian infants. J Pediatr. 1995;126:102–108
  10. Ebbesen F, Andersson C, Verder H, et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr. 2005;94:59–64
  11. American Academy of Pediatrics . Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316
  12. Canadian Paediatric Society . Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation). Paediatr Child Health. 2007;12:1B–12
  13. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant ≥35 weeks' gestation: an update with clarifications. Pediatrics. 2009;124:1193–1198
  14. Bertini G, Dani C, Trochin M, Rubaltelli F. Is breast feeding really favoring early neonatal jaundice?. Available at: Pediatrics. 2001;107;http://www.pediatrics.org/cgi/content/full/101/2/e41
  15. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140–1147
  16. Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast feeding. Pediatrics. 1986;78:837–843
  17. Maisels MJ, DeRidder JM, Kring EA, Balasubramaniam M. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol. 2009;29:612–617
  18. Schneider AP. Breast milk jaundice in the newborn. A real entity. J Am Med Assoc. 1986;255:3270–3274
  19. Maisels MJ, Gifford K, Antle CE, Leib GR. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics. 1988;81:505–511
  20. De Carvalho M, Klaus MH, Merkatz RB. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child. 1982;136:737–738
  21. Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics. 1990;86:171–175
  22. Gourley GR. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol. 2002;7:135–141
  23. Auerbach KG, Gartner LM. Breast feeding and human milk: their association with jaundice in the neonate. Clin Perinatol. 1987;14:89–107
  24. Gärtner U, Goeser T, Wolkoff AW. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology. 1997;113:1707–1713
  25. Fevery J. Fasting hyperbilirubinemia: unraveling the mechanism involved. Gastroenterology. 1997;113:1798–1800
  26. De Carvalho M, Robertson S, Klaus M. Fecal bilirubin excretion and serum bilirubin concentration in breast-fed and bottle-fed infants. J Pediatr. 1985;107:786–790
  27. Gourley GR, Kreamer B, Arend R. The effect of diet on feces and jaundice during the first three weeks of life. Gastroenterology. 1992;103:660
  28. Verkade HJ. A novel hypothesis on the pathophysiology of neonatal jaundice. J Pediatr. 2002;141:594–595
  29. Nishioka T, Hafkamp AM, Havinga R, Van Lierop PPE, Velvis H, Verkade HJ. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic gunn rats. J Pediatr. 2003;143:327–334
  30. Gourley GR. Pathophysiology of breast-milk jaundice. In:  Polin RA,  Fox WW editor. Fetal and neonatal physiology. Philadelphia: Saunders; 1998;p. 1499
  31. Yoshioka H. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics. 1983;72:317–321
  32. Gourley GR, Arend RA. Beta-glucuronidase and hyperbilirubinemia in breast-fed and formula-fed babies. Lancet. 1986;1:644–646
  33. Sirota L, Ferrera M, Lerer N, Dulitzky F. Beta-glucuronidase and hyperbilirubinaemia in breast fed infants of diabetic mothers. Arch Dis Child. 1992;67:120–121
  34. Monaghan G, McLellan A, McGeehan A, et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr. 1999;134:441–446
  35. Maisels MJ. Jaundice. In:  MacDonald MG,  Seshia MMK,  Mullett MD editor. Avery's Neonatology. Philadelphia, PA: Lippincott Co.; 2005;p. 768–846
  36. Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 or more weeks' of gestation. Pediatrics. 2006;117:1169–1173
  37. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns. Pediatrics. 1999;103:6–14
  38. Davidson LT, Merritt KK, Weech AA. Hyperbilirubinemia in the newborn. Am J Dis Child. 1941;61:958–980
  39. Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000;154:391–394
  40. Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child. 1969;118:454–458
  41. Madlon-Kay DJ. Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics. 1997;100:e3
  42. Riskin A, Abend-Weinger M, Bader D. How accurate are neonatologists in identifying clinical jaundice in newborns?. Clin Pediatr. 2003;42:153–158
  43. Szabo P, Wolf M, Bucher HU, Fauchère JC, Haensse D, Arlettaz R. Detection of hyperbilirubinaemia in jaundiced full-term neonates by eye or by bilirubinometer?. Eur J Pediatr. 2004;163:722–727
  44. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani V. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121:e170–179
  45. Maisels MJ, DeRidder J, Kring E. Transcutaneous bilirubin (TcB) levels in outpatient practice. E-PAS. 2007;618441.5
  46. Engle W, Jackson GC, Stehel EK, Sendelbach D, Manning MD. Evaluation of a transcutaneous jaundice meter following hospital discharge in term and near-term neonates. J Perinatol. 2005;25:486–490
  47. Maisels MJ, Artinian F, Engle W, McManus S, Wainer S. Transcutaneous bilirubin (TcB) levels in a mixed race outpatient population – use of a new approach. E-PAS. 2009;2842.398
  48. Maisels MJ. Transcutaneous bilirubinometry. Neoreviews. 2006;7:e217–e225
  49. Maisels MJ, Kring E. Trancutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics. 1997;99:599–601
  50. Dai J, Krahn J, Parry DM. Clinical impact of transcutaneous bilirubinometry as an adjunctive screen for hyperbilirubinemia. Clin Biol. 1996;29:581–586
  51. Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr. 2002;91:203–211
  52. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108:31–39
  53. Alpay F, Sarici S, Tosuncuk HD, Serdar MA, Inanc N, Gokcay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics. 2000;106:E16
  54. Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr. 2001;90:166–170
  55. Kaplan M, Hammerman C, Feldman R, Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2000;105:533–537
  56. Newman T, Liljestrand P, Escobar G. Combining clinical risk factors with bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med. 2005;159:113–119
  57. Newman TB. Universal bilirubin screening, guidelines, and evidence. Pediatrics. 2009;124:1199–1202
  58. Trikalinos T, Chung M, Lau J, Ip S. Systematic review of screening for bilirubin encephalopathy in neonates. Pediatrics. 2009;124:1162–1171
  59. US Preventive Services Task Force (USPSTF) . Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: U.S. Preventive Services Task Force recommendation statement. Pediatrics. 2009;124:1172–1177
  60. Kuzniewicz MW, Escobar GJ, Newman TB. The impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use in a managed care organization. Pediatrics. 2009;124:1031–1039
  61. Eggert L, Wiedmeier SE, Wilson J, Christensen R. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117:e855–e862
  62. Longhurst C, Turner S, Burgos AE. Development of a web-based decision support tool to increase use of neonatal hyperbilirubinemia guidelines. Jt Comm J Qual Patient Saf. 2009;35:256–262
  63. National Quality Forum . Serious reportable events in healthcare: a consensus report. Washington, DC: National Quality Forum; 2002;
  64. Davidson L, Thilo EH. How to make kernicterus a “never event”. Neoreviews. 2003;4:308–314
  65. Auerbach AD, Landefeld CS, Shojania K. The tension between needing to improve care and knowing how to do it. N Engl J Med. 2007;357:608–613

    *The most important references are indicated with an asterisks.

PII: S1744-165X(09)00104-8

doi: 10.1016/j.siny.2009.10.004

Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 129-135 , June 2010

Article Tools

* Image Usage & Resolution